SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-16-015620
Filing Date
2016-05-27
Accepted
2016-05-27 17:05:26
Documents
6
Period of Report
2016-05-26
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1601433_8k.htm 8-K 41098
2 EXHIBIT 3.1 t1601433_ex3-1.htm EX-3.1 8574
3 EXHIBIT 3.2 t1601433_ex3-2.htm EX-3.2 125441
4 EXHIBIT 99.1 t1601433_ex99-1.htm EX-99.1 12945
5 GRAPHIC complogo.jpg GRAPHIC 10000
6 GRAPHIC pressrel.jpg GRAPHIC 3422
  Complete submission text file 0001571049-16-015620.txt   208261
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 161683167
SIC: 2834 Pharmaceutical Preparations